Open Access
Open access
volume 24 issue 23 pages 4229

Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application

Publication typeJournal Article
Publication date2019-11-21
scimago Q1
wos Q2
SJR0.865
CiteScore8.6
Impact factor4.6
ISSN14203049
Organic Chemistry
Drug Discovery
Physical and Theoretical Chemistry
Pharmaceutical Science
Molecular Medicine
Analytical Chemistry
Chemistry (miscellaneous)
Abstract
Aptamers are short, single-stranded oligonucleotides that bind to specific target molecules. The shape-forming feature of single-stranded oligonucleotides provides high affinity and excellent specificity toward targets. Hence, aptamers can be used as analogs of antibodies. In December 2004, the US Food and Drug Administration approved the first aptamer-based therapeutic, pegaptanib (Macugen), targeting vascular endothelial growth factor, for the treatment of age-related macular degeneration. Since then, however, no aptamer medication for public health has appeared. During these relatively silent years, many trials and improvements of aptamer therapeutics have been performed, opening multiple novel directions for the therapeutic application of aptamers. This review summarizes the basic characteristics of aptamers and the chemical modifications available for aptamer therapeutics.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
8
International Journal of Molecular Sciences
8 publications, 3.19%
Biosensors
7 publications, 2.79%
Chemical Reviews
6 publications, 2.39%
Molecules
5 publications, 1.99%
Progress in Molecular Biology and Translational Science
5 publications, 1.99%
Sensors
4 publications, 1.59%
Advanced Drug Delivery Reviews
4 publications, 1.59%
ACS Omega
4 publications, 1.59%
Biomedicines
3 publications, 1.2%
Frontiers in Cell and Developmental Biology
3 publications, 1.2%
Biosensors and Bioelectronics: X
3 publications, 1.2%
Journal of Drug Delivery Science and Technology
3 publications, 1.2%
Analytical Chemistry
3 publications, 1.2%
Chemosensors
3 publications, 1.2%
Talanta
3 publications, 1.2%
Microchimica Acta
3 publications, 1.2%
Biosensors and Bioelectronics
3 publications, 1.2%
The Analyst
3 publications, 1.2%
Nucleic Acid Therapeutics
2 publications, 0.8%
Micromachines
2 publications, 0.8%
Cancers
2 publications, 0.8%
Analytical and Bioanalytical Chemistry
2 publications, 0.8%
Drug Discovery Today
2 publications, 0.8%
Microchemical Journal
2 publications, 0.8%
Colloids and Surfaces B: Biointerfaces
2 publications, 0.8%
Life Sciences
2 publications, 0.8%
Sensors and Actuators, B: Chemical
2 publications, 0.8%
Methods
2 publications, 0.8%
Biotechnology Progress
2 publications, 0.8%
1
2
3
4
5
6
7
8

Publishers

10
20
30
40
50
60
70
Elsevier
65 publications, 25.9%
MDPI
46 publications, 18.33%
Springer Nature
28 publications, 11.16%
American Chemical Society (ACS)
24 publications, 9.56%
Wiley
21 publications, 8.37%
Royal Society of Chemistry (RSC)
10 publications, 3.98%
Taylor & Francis
9 publications, 3.59%
Frontiers Media S.A.
9 publications, 3.59%
Pleiades Publishing
5 publications, 1.99%
Mary Ann Liebert
3 publications, 1.2%
Cold Spring Harbor Laboratory
3 publications, 1.2%
SPIE-Intl Soc Optical Eng
1 publication, 0.4%
IOP Publishing
1 publication, 0.4%
Xi'an Jiaotong University
1 publication, 0.4%
SAGE
1 publication, 0.4%
Open Exploration Publishing
1 publication, 0.4%
American Society for Biochemistry and Molecular Biology
1 publication, 0.4%
SciELO
1 publication, 0.4%
Public Library of Science (PLoS)
1 publication, 0.4%
American Society of Hematology
1 publication, 0.4%
Baishideng Publishing Group
1 publication, 0.4%
Scientific Scholar
1 publication, 0.4%
The Electrochemical Society
1 publication, 0.4%
Walter de Gruyter
1 publication, 0.4%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.4%
OAE Publishing Inc.
1 publication, 0.4%
Acta Naturae Ltd
1 publication, 0.4%
The Company of Biologists
1 publication, 0.4%
Oxford University Press
1 publication, 0.4%
10
20
30
40
50
60
70
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
251
Share
Cite this
GOST |
Cite this
GOST Copy
Adachi, NAKAMURA Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application // Molecules. 2019. Vol. 24. No. 23. p. 4229.
GOST all authors (up to 50) Copy
Adachi, NAKAMURA Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application // Molecules. 2019. Vol. 24. No. 23. p. 4229.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/molecules24234229
UR - https://doi.org/10.3390/molecules24234229
TI - Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
T2 - Molecules
AU - Adachi
AU - NAKAMURA
PY - 2019
DA - 2019/11/21
PB - MDPI
SP - 4229
IS - 23
VL - 24
PMID - 31766318
SN - 1420-3049
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Adachi,
author = {Adachi and NAKAMURA},
title = {Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application},
journal = {Molecules},
year = {2019},
volume = {24},
publisher = {MDPI},
month = {nov},
url = {https://doi.org/10.3390/molecules24234229},
number = {23},
pages = {4229},
doi = {10.3390/molecules24234229}
}
MLA
Cite this
MLA Copy
Adachi, et al. “Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.” Molecules, vol. 24, no. 23, Nov. 2019, p. 4229. https://doi.org/10.3390/molecules24234229.